Multipurpose prevention technologies: the future of HIV and STI protection - Test2 - elhamkhani - TriplyDB

Multipurpose prevention technologies: the future of HIV and STI protection

Multipurpose prevention technologies: the future of HIV and STI protection

http://www.wikidata.org/entity/Q26827796

about

Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experiment Trichomoniasis - are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide?Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea.In Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical Mucosa First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics.Gene expression patterns in transgenic mouse models of hypertrophic cardiomyopathy caused by mutations in myosin regulatory light chain.Attitudes and perceptions towards novel objective measures of ARV-based vaginal ring use: Results from a global stakeholder survey.An update on multipurpose prevention technologies for the prevention of HIV transmission and pregnancy.MZC Gel Inhibits SHIV-RT and HSV-2 in Macaque Vaginal Mucosa and SHIV-RT in Rectal Mucosa.MIV-150 and zinc acetate combination provides potent and broad activity against HIV-1.An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques.Screening for Sexually Transmitted Infections in Antenatal Care Is Especially Important Among HIV-Infected Women Contraceptive Practice in Sub-Saharan Africa.The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa.The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention.A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use.Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides.Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo

P2860

Q26753097-E0DA9E57-47B5-456C-9C7B-B1586C86A3C5 Q28596813-73F3F075-DDC4-4E17-A2A8-9708C9D3886D Q30235029-E7572327-31E5-447C-BF9C-E3FB6DE3643F Q37076884-67C3476B-C4ED-43CE-B5F1-FBC7740BD3A7 Q37203838-BBDD8FCF-7D34-46EC-802D-3C443778ABFE Q37520083-3BA0BC87-4D92-4995-A217-3D4C0B6B480A Q37726526-FAFA667A-C237-4D9D-96BC-757C9C5D0C7C Q38678847-19965D79-0D54-46F5-B6D8-25AD236FB1F3 Q38689686-DCFFFDCC-5ADF-41C0-B31F-575D6A47F284 Q39463175-303D6971-0D19-45F0-8BAC-928E76E543AA Q40081674-304F9F53-D50E-4C3C-857F-E4D9557519D3 Q40165275-417505A4-0AC4-4233-8A41-59415D48042C Q42360817-557CCB20-0651-41C2-B91C-C22BDB357CA4 Q46663039-8235E0F7-A1E9-47A8-A6F4-B3F18D8BFFE7 Q52656286-402541C7-E742-4FDE-A9A5-FF2BF091F630 Q53422440-B1041149-5110-4DD7-9FCB-59C4860632ED Q55101908-25DB318E-3C6D-42FF-9447-77A7066DCF48 Q55436855-644FEE51-471F-4015-AD30-FCB7D3E1EC91 Q58700581-CBD91A1F-DAF8-4E4A-84A9-32E6BF964510

P2860

Multipurpose prevention technologies: the future of HIV and STI protection

http://www.wikidata.org/entity/Q26827796

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Multipurpose prevention technologies: the future of HIV and STI protection

@ast

Multipurpose prevention technologies: the future of HIV and STI protection

@en

Multipurpose prevention technologies: the future of HIV and STI protection

@nl

type

label

Multipurpose prevention technologies: the future of HIV and STI protection

@ast

Multipurpose prevention technologies: the future of HIV and STI protection

@en

Multipurpose prevention technologies: the future of HIV and STI protection

@nl

prefLabel

Multipurpose prevention technologies: the future of HIV and STI protection

@ast

Multipurpose prevention technologies: the future of HIV and STI protection

@en

Multipurpose prevention technologies: the future of HIV and STI protection

@nl

P1433

Q26827796-B13348EC-2B59-41A3-8EF3-481D7884F9EA

P1476

Q26827796-21F99ADC-F19B-4756-B358-7576D6F6CF52

P2093

Q26827796-11F1CFE5-FB97-4489-B96E-BDA98A0A9EA3

Q26827796-3211AF85-741E-40C2-A435-4B42CEE35426

Q26827796-5254F960-2991-4E72-9AB1-BC3A4290A654

Q26827796-77DCF338-2F18-4491-808C-6537F749D9E2

Q26827796-970F6E82-C236-4D70-84C7-D0EBF200DC57

Q26827796-A6E9420F-06AB-4549-9B4D-8E7B27B9B634

Q26827796-B1B4CB9D-EE3C-41B5-8278-87B0C068B98B

Q26827796-C7340DF5-6DE0-4923-B4E8-A3A5879534FB

Q26827796-EDED43F2-4CEC-47CA-9280-A544717DF966

P2860

Q26827796-0399A83F-30C4-46D6-85BF-41254087CAC2

Q26827796-114361AF-EB66-413B-958C-0C9D2B8DBED6

Q26827796-143853D2-96B0-419C-989C-458FE3E53950

Q26827796-1F5DE9BD-264D-4B61-A303-AAD95A4C5461

Q26827796-22155539-E8FF-459A-B748-62166679A68A

Q26827796-23528466-6663-401D-AFB6-3A55F755225B

Q26827796-2BBBA96A-7456-4256-B1A9-3D5086A2D120

Q26827796-2CAD10BA-935F-42A1-9858-F313D5197379

Q26827796-3064BE62-2E5F-4D7D-9B8F-5E5A1BFFC064

Q26827796-30DB1B3B-CA5C-4521-8B93-8409087C38F9

P304

Q26827796-DB25D2EC-7449-4935-9CC4-B0B5DC784838

P31

Q26827796-EB8DC0CD-CC84-4812-A512-75DD76C72F90

P3181

Q26827796-227FE8B9-365B-4DB0-B19D-28B22C3B5860

P356

Q26827796-F3CA7372-AAAF-45ED-96FD-613FF6BC1A31

P407

Q26827796-C0A5E72A-EBE6-4F43-AF49-70190E93F2CA

P433

Q26827796-4F2DF345-37C2-4C32-9FFC-3FCEC529F99E

P478

Q26827796-919BFBA9-B5D5-462E-893F-461FA735FBA4

P577

Q26827796-9CCBC18B-1BF4-45DA-BEDD-5E1FD0665385

P5875

Q26827796-AB17D2E8-775E-4224-A8D6-4D047460D7BB

P698

Q26827796-9B4B67B8-B0BE-4B14-970D-5A86D35A8AB4

P921

Q26827796-8AD15907-5610-4484-8A41-6E5712DC185B

P932

Q26827796-F43ABFE7-593A-481C-A25A-3935C9DD28FE

P3181

P356

J.TIM.2015.02.006

P1433

Trends in Microbiology

P1476

Multipurpose prevention technologies: the future of HIV and STI protection

@en

P2093

Betsy C. Herold

http://www.w3.org/2001/XMLSchema#string

Carolyn Deal

http://www.w3.org/2001/XMLSchema#string

Christopher D. Petro

http://www.w3.org/2001/XMLSchema#string

Dorothy Patton

http://www.w3.org/2001/XMLSchema#string

Joe Romano

http://www.w3.org/2001/XMLSchema#string

John Schiller

http://www.w3.org/2001/XMLSchema#string

José A. Fernández-Romero

http://www.w3.org/2001/XMLSchema#string

Manjulaa Narasimhan

http://www.w3.org/2001/XMLSchema#string

Thomas Zydowsky

http://www.w3.org/2001/XMLSchema#string

P2860

Carrageenan is a potent inhibitor of papillomavirus infection

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection

Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component

Herpes simplex virus type 2 and HIV disease progression: a systematic review of observational studies

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp

Preexposure prophylaxis for HIV infection among African women

Tenofovir-based preexposure prophylaxis for HIV infection among African women.

Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial.

P304

429-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4496576

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.TIM.2015.02.006

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273256771

http://www.w3.org/2001/XMLSchema#string

P698

25759332

http://www.w3.org/2001/XMLSchema#string

P921

prevention of HIV/AIDS

P932

4490993

http://www.w3.org/2001/XMLSchema#string